Bone extracellular matrix

The **bone extracellular matrix (ECM)** is not a single molecular target or receptor, but rather the composite structural network forming the scaffold of bone tissue[6][2][3][4]. It consists of both mineral (mainly hydroxyapatite) and organic (primarily type I collagen, plus proteoglycans and a wide variety of non-collagenous proteins) components[3][6]. The bone ECM enables bone strength, elasticity, and plasticity, and acts as a key compartment for mineral storage, mechanical support, and the regulation of cellular processes in bone formation and remodeling[2][4][6]. Key signaling molecules (e.g., transforming growth factor-β, bone morphogenetic proteins), receptors, and growth factors are either sequestered within or act upon the ECM to orchestrate osteoblast and osteoclast differentiation and function[6][1][4]. Drug modulation of the bone ECM occurs indirectly through targets that mediate the processes of matrix synthesis (by osteoblasts) and resorption (by osteoclasts), which are critical in metabolic bone diseases and regenerative medicine[2][6][1]. **Note:** "Bone extracellular matrix formation" is a biological process, not a specific drug target or molecular entity; therefore, it is not considered a canonical therapeutic target and this entry is marked as incorrect for that purpose. If your intent is to focus on a single canonical protein (e.g., type I collagen, fibronectin, or a specific growth factor), further specification is required.

Other names

Bone ECMExtracellular matrix of bone

Inhibition of osteoclast-mediated bone resorption (e.g., bisphosphonates, denosumab) Stimulation of bone formation (e.g., parathyroid hormone analogs) Regulation of bone remodeling signaling pathways (RANKL, TGF-β, Wnt/sclerostin)